|
||
Original Article |
B Activation, and Bcl-XL Levels In Vivo
Correspondence to: Pamela S. Ohashi, Department of Medical Biophysics, University of Toronto, Ontario Cancer Institute, 610 University Ave., Toronto, Ontario M5G 2M9, Canada. Tel:416-946-4501, ext. 5470 Fax:416-946-2086 E-mail:pohashi{at}oci.utoronto.ca.
The serine/threonine kinase protein kinase B (PKB)/Akt mediates cell survival in a variety of systems. We have generated transgenic mice expressing a constitutively active form of PKB (gag-PKB) to examine the effects of PKB activity on T lymphocyte survival. Thymocytes and mature T cells overexpressing gag-PKB displayed increased active PKB, enhanced viability in culture, and resistance to a variety of apoptotic stimuli. PKB activity prolonged the survival of CD4+CD8+ double positive (DP) thymocytes in fetal thymic organ culture, but was unable to prevent antigen-induced clonal deletion of thymocytes expressing the major histocompatibility complex class Irestricted P14 T cell receptor (TCR). In mature T lymphocytes, PKB can be activated in response to TCR stimulation, and peptide-antigenspecific proliferation is enhanced in T cells expressing the gag-PKB transgene. Both thymocytes and T cells overexpressing gag-PKB displayed elevated levels of the antiapoptotic molecule Bcl-XL. In addition, the activation of peripheral T cells led to enhanced nuclear factor (NF)-
B activation via accelerated degradation of the NF-
B inhibitory protein I
B
. Our data highlight a physiological role for PKB in promoting survival of DP thymocytes and mature T cells, and provide evidence for the direct association of three major survival molecules (PKB, Bcl-XL, and NF-
B) in vivo in T lymphocytes.
Key Words:
PKB/Akt, Bcl-XL, apoptosis, thymocyte selection, NF-
B
This article has been cited by other articles:
| TABLE OF CONTENTS |
|